Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250003, China.
Microbiome-X, National Institute of Health Data Science of China, Cheeloo College of Medicine, Shandong University, Jinan, 25000, China.
J Transl Med. 2022 Oct 8;20(1):459. doi: 10.1186/s12967-022-03669-0.
BACKGROUND: Integrative analysis approaches of metagenomics and metabolomics have been widely developed to understand the association between disease and the gut microbiome. However, the different profiling patterns of different metabolic samples in the association analysis make it a matter of concern which type of sample is the most closely associated with gut microbes and disease. To address this lack of knowledge, we investigated the association between the gut microbiome and metabolomic profiles of stool, urine, and plasma samples from ischemic stroke patients and healthy subjects. METHODS: We performed metagenomic sequencing (feces) and untargeted metabolomics analysis (feces, plasma, and urine) from ischemic stroke patients and healthy volunteers. Differential analyses were conducted to find key differential microbiota and metabolites for ischemic stroke. Meanwhile, Spearman's rank correlation and linear regression analyses were used to study the association between microbiota and metabolites of different metabolic mixtures. RESULTS: Untargeted metabolomics analysis shows that feces had the most abundant features and identified metabolites, followed by urine and plasma. Feces had the highest number of differential metabolites between ischemic stroke patients and the healthy group. Based on the association analysis between metagenomics and metabolomics of fecal, urine, and plasma, fecal metabolome showed the strongest association with the gut microbiome. There are 1073, 191, and 81 statistically significant pairs (P < 0.05) in the correlation analysis for fecal, urine, and plasma metabolome. Fecal metabolites explained the variance of alpha-diversity of the gut microbiome up to 31.1%, while urine and plasma metabolites only explained the variance of alpha-diversity up to 13.5% and 10.6%. Meanwhile, there were more significant differential metabolites in feces than urine and plasma associated with the stroke marker bacteria. CONCLUSIONS: The systematic association analysis between gut microbiome and metabolomics reveals that fecal metabolites show the strongest association with the gut microbiome, followed by urine and plasma. The findings would promote the association study between the gut microbiome and fecal metabolome to explore key factors that are associated with diseases. We also provide a user-friendly web server and a R package to facilitate researchers to conduct the association analysis of gut microbiome and metabolomics.
背景: 元基因组学和代谢组学的综合分析方法已经被广泛开发,以了解疾病与肠道微生物组之间的关联。然而,在关联分析中,不同代谢样本的不同分析模式引起了人们的关注,即哪种类型的样本与肠道微生物和疾病的关联最密切。为了解决这方面的知识空白,我们调查了缺血性脑卒中患者和健康受试者的粪便、尿液和血浆样本的肠道微生物组与代谢组学图谱之间的关联。
方法: 我们对缺血性脑卒中患者和健康志愿者的粪便进行了元基因组测序(粪便)和非靶向代谢组学分析(粪便、血浆和尿液)。进行差异分析以找到缺血性脑卒中的关键差异微生物群和代谢物。同时,使用 Spearman 秩相关和线性回归分析来研究不同代谢混合物的微生物群和代谢物之间的关联。
结果: 非靶向代谢组学分析表明,粪便具有最丰富的特征和鉴定出的代谢物,其次是尿液和血浆。粪便中缺血性脑卒中患者与健康组之间的差异代谢物数量最多。基于粪便、尿液和血浆的元基因组学和代谢组学之间的关联分析,粪便代谢组与肠道微生物组的关联最强。在粪便、尿液和血浆代谢组的相关性分析中,有 1073、191 和 81 对具有统计学意义的配对(P < 0.05)。粪便代谢物可解释肠道微生物组 α多样性的变化高达 31.1%,而尿液和血浆代谢物仅可解释 α 多样性的变化高达 13.5%和 10.6%。同时,粪便中与脑卒中标志物细菌相关的差异代谢物比尿液和血浆中更多。
结论: 肠道微生物组与代谢组学的系统关联分析表明,粪便代谢物与肠道微生物组的关联最强,其次是尿液和血浆。这些发现将促进肠道微生物组与粪便代谢组之间的关联研究,以探索与疾病相关的关键因素。我们还提供了一个用户友好的网络服务器和一个 R 包,以方便研究人员进行肠道微生物组和代谢组学的关联分析。
Front Cell Infect Microbiol. 2023
Front Cell Infect Microbiol. 2018-8-28
Front Cell Infect Microbiol. 2021
Front Cardiovasc Med. 2025-7-22
Front Cell Infect Microbiol. 2025-6-23
Front Cell Neurosci. 2025-4-17
J Microbiol Biotechnol. 2025-3-11
Front Cardiovasc Med. 2021-12-23
Front Cell Infect Microbiol. 2021
Front Aging Neurosci. 2021-7-30
J Clin Invest. 2021-1-19
Protein Cell. 2021-5
Int J Mol Sci. 2020-9-14